News
A total of 5 analyst ratings have been received for Teva Pharmaceutical Indus, with the consensus rating being Buy. The ...
For reference, Seeking Alpha's Quant system is driven by powerful computer processing and SA's special 'Quantamental' ...
StockStory.org on MSN14h
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
A recently launched video series from the Biotechnology Innovation Organization (BIO) seeks to show how biotech may be able ...
Indiana Attorney General Todd Rokita has secured $720 million in settlements with eight drug makers that manufacture opioid ...
Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...
LAVAL, QC / ACCESS Newswire / / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced the appointment of Michael Goettler and Sandra Leung ...
5d
Pharmaceutical Technology on MSNNovo Nordisk defeated in Wegovy patent dispute by Viatris
The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
Shares of Viatris Inc. VTRS advanced 1.41% to $9.37 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.78% to 6,358.91 and ...
Attorney General Alan Wilson announced approximately $720 million nationwide in settlements with eight drug makers that ...
Viatris Inc.'s proposed copy of Novo Nordisk A/S’ Wegovy doesn’t infringe a patent on using the once-weekly obesity drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results